These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9233837)

  • 41. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
    Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
    Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo.
    Zhang K; Chow PK
    Clin Cancer Res; 2004 Aug; 10(15):5226-32. PubMed ID: 15297426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
    Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circumvention of multidrug resistance and reduction of cardiotoxicity of doxorubicin in vivo by coupling it with low density lipoprotein.
    Lo EH; Ooi VE; Fung KP
    Life Sci; 2002 Dec; 72(6):677-87. PubMed ID: 12467908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
    Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
    Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
    Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.
    Zhai BJ; Shao ZY; Zhao CL; Hu K; Wu F
    World J Gastroenterol; 2006 Nov; 12(41):6614-9. PubMed ID: 17075973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.
    Xiao S; Wang Y; Ma W; Zhou P; Wang B; Wu Z; Wen Q; Xiong K; Liu Y; Fu S
    Drug Deliv; 2022 Dec; 29(1):2713-2722. PubMed ID: 35975331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
    Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
    Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    World J Gastroenterol; 2005 Apr; 11(16):2431-7. PubMed ID: 15832413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Screening of the drug resistance-associated gene in HepG2 cell line transfected with aldose reductase like gene-1 (ARL-1)].
    Yang XD; Tang DN; Wang J; Cao DL
    Ai Zheng; 2003 Dec; 22(12):1289-95. PubMed ID: 14693054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Targeting therapy with adriamycin-monoclonal antibody (HAb18) conjugate in nude mice with human hepatocellular carcinoma xenografts].
    Sui Y
    Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):397-400, 445. PubMed ID: 1330227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
    Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
    Yeh CB; Su CJ; Hwang JM; Chou MC
    Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
    Fan YZ; Zhao ZM; Fu JY; Chen CQ
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):618-22. PubMed ID: 16784656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine].
    Ding L; Chen XP; Zhang ZW; Zhang WG; Cao B; Wang ZH; Li CL
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):353-7. PubMed ID: 16732910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inhibitory effect of norcantharidin combined with evodiamine on the growth of human hepatic carcinoma cell line HepG2 in vitro].
    Liu Y; Zahng J; You Z; Liao H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):824-8. PubMed ID: 25108435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.